Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 8, 1998

View Archived Issues

Novel actions of statins reported at the 20th Congress of the European Society of Cardiology

UC-781: stability in gel formulation, anti-HIV activity

CP-154526, a CRF1 receptor antagonist, reduces stress-induced relapse of drug use in rats

Ribozyme: Q2 1998 highlights

Aviron: Q2 and HY fiscal 1998 highlights

CytRx: Q2 1998 highlights

Texas Biotechnology: Q2 1998 highlights

Purlytin enters development for prostate cancer; another cancer indication abandoned

Licensing and/or CRADA opportunity: drug and method to prevent and treat graft-vs.-host disease

Licensing opportunity from NIH: method of inducing increased resistance to stroke

Potent factor Xa inhibitors from RPR for thromboembolic disorders

Schering AG describes new progestogenic steroids

Nymox discovers new treatment for E. coli 0157:H7 infection

New antibacterial/antitumor agents produced by fungal strains discovered by Kyowa Hakko

Millennium reports advances in the diagnosis, treatment of type II diabetes

Lilly research leads to dual tachykinin antagonists/5-HT agonists

Hoechst increases shareholding in Korean joint venture

Ligand reveals tissue-selective, orally active progestational compound

Broad-spectrum antiviral agents in development at Pfizer

Canadian academic researchers identify estrone sulfatase inhibitors

Gilead announces new clinical trials with GS-1278

Biora: Q2 1998 highlights

Novel lipid-lowering agent presented by Wayne Hughes Institute at scientific forum

Lilly's mGlu agonists exert neuroprotective effects in vivo

Schwarz to market rectal morphine product developed by Core

Pfizer selects GH secretagogue as development candidate

UroCor introduces urine test to identify aggressive bladder cancers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...